Lixte Biotechnology Inc.

NASDAQ: LIXT · Real-Time Price · USD
3.56
-0.34 (-8.72%)
At close: Aug 15, 2025, 3:59 PM
3.62
1.69%
After-hours: Aug 15, 2025, 05:16 PM EDT

Lixte Biotechnology Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-1.27 -0.88 -1.28 -2.38
PEG Ratio
0.03 0.03 0.06 -0.03
PS Ratio
n/a n/a n/a n/a
PB Ratio
5.52 1.12 1.56 3.35
P/FCF Ratio
-1.44 -1.05 -1.75 -3.87
P/OCF Ratio
-1.44 -1.05 -1.75 -3.87
OCF/S Ratio
n/a n/a n/a n/a
Debt / Equity Ratio
n/a n/a n/a n/a
Quick Ratio
3.26 13.73 14.08 16.81
Current Ratio
3.26 13.73 14.08 16.81
Asset Turnover
n/a n/a n/a n/a
Interest Coverage
n/a n/a -711.15 -906.45
Return on Equity
-4.34 -1.27 -1.22 -1.4
Return on Assets
-3.13 -1.18 -1.14 -1.32
Return on Invested Capital
-4.32 -1.27 -1.19 -1.36
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a n/a n/a
Net Profit Margin
n/a n/a n/a n/a
Pretax Profit Margin
n/a n/a n/a n/a
Operating Profit Margin
n/a n/a n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a n/a n/a